Erschienen in:
01.08.2010 | Case Report
Successful treatment of choroidal neovascular membrane in retinitis pigmentosa with intravitreal bevacizumab
verfasst von:
Archana Malik, Sunandan Sood, Subina Narang
Erschienen in:
International Ophthalmology
|
Ausgabe 4/2010
Einloggen, um Zugang zu erhalten
Abstract
We report a rare association of choroidal neovascularization (CNV) with retinitis pigmentosa and note its resolution by intravitreal injection of the anti-vascular endothelial growth factor (VEGF), bevacizumab. A classic choroidal neovascular membrane was seen in the right eye (RE) of a patient with sector retinitis pigmentosa. Bevacizumab 1.25 mg in 0.05 ml was injected intravitreally. The choroidal neovascular membrane was seen to regress following this single intravitreal bevacizumab injection with formation of a scar. CNV has very rarely been seen in association with retinitis pigmentosa. Anti-VEGF drugs have been shown to have a beneficial role in CNV with other causes; in this case their effectiveness in CNV associated with retinal dystrophies, for example retinitis pigmentosa, has been demonstrated.